Skip to main content
Premium Trial:

Request an Annual Quote

NIDA Plans to Fund Epigenomics of HIV

NEW YORK (GenomeWeb News) – The National Institute on Drug Abuse plans to fund research that will use epigenomics approaches to study HIV and how it is linked to substance abuse, the National Institutes of Health said in a notice posted on its website.

NIDA expects to fund "a broad range of interdisciplinary research, using in vitro, animal and human approaches to address these interactions," NIH said.

The R01 and the R21 grants could fund epigenomics regulation of HIV infection, epigenomics processes associated with specific patterns of disease progression in individuals with a history of substance abuse, and the effects of epigenomics changes associated with drug abuse on HIV infection and disease progression.

These studies must focus on HIV/AIDS, and they must have a significant epigenomics or non-coding RNA component, and must include a component related to drugs of abuse.

Studies that use samples from drug-abusing populations or in vivo or in vitro model systems would be appropriate for these grants, NIH said.

NIH expects to publish the RFA in September with an expected receipt date in December.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.